 "Black fungus: 106,300 vials of Amphotericin-B allocated to states, UTs")
Union Minister for Chemicals and Fertilisers DV Sadananda Gowda on Monday said that 1,06,300 vials of black fungus drugs Amphotericin B have been allocated to states, union territories and to the Central Institutions.
"Ensuring significant availability of Liposomal #Amphotericin B, additional 106300 vials of the drug have been allocated across all the States/UTs and Central Institutions today," Sadananda Gowda said in a tweet.
The Minister said that a total of 53,000 vials of Conventional Amphotericin B have also been allocated to all the states, UTs and Central Institutions today.
"A total of 53,000 vials of Conventional #Amphotericin B have also been allocated to all the States/UTs & Central Institutions today. The allocation of #ConventionalAmphotericin B is being made to ensure its smooth supply and timely treatment of patients," he said in another tweet.
He further said that additional 9,400 vials of Liposomal Amphotericin B and 4,680 vials of Conventional Amphotericin B have been allocated to Karnataka today.
"Additional 9,400 vials of Liposomal Amphotericin B have been allocated to Karnataka today. So far, total 49,870 vials of the drug have been made to the state. Besides this, 4,680 vials of Conventional Amphotericin B have also been allocated to Karnataka today," he added.
On May 27, the Central government gave a licence to five companies to ramp up the production of Liposomal Amphotericin B injections, which is used to treat black fungus or mucormycosis.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app